RBL-001 + RBL-002 RNA vaccine(BioNTech)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameRBL-001 + RBL-002 RNA vaccine(BioNTech)

Drug Alias Namerecombinant RNA cancer vaccine (Ribological)intranodal recombinant RNA cancer vaccine (Ribological)RBL-001RBL-002

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionCancer/testis antigen 1 modulatorsImmunomodulatorsTyrosinase modulators

TargetsTyrosinaseCancer/testis antigen 1

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustriaGermany

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiontech Rna Pharmaceuticals Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiontech Rna Pharmaceuticals Gmbh

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A